Kintor Pharmaceutical Limited (9939.HK)

HKD 1.1

(-0.9%)

Long Term Debt Summary of Kintor Pharmaceutical Limited

  • Kintor Pharmaceutical Limited's latest annual long term debt in 2023 was 135.69 Million CNY , up 76302.03% from previous year.
  • Kintor Pharmaceutical Limited's latest quarterly long term debt in 2023 FY was 135.69 Million CNY , up 76302.03% from previous quarter.
  • Kintor Pharmaceutical Limited reported annual long term debt of 177.6 Thousand CNY in 2022, up 20.41% from previous year.
  • Kintor Pharmaceutical Limited reported annual long term debt of 147.5 Thousand CNY in 2021, up 9.34% from previous year.
  • Kintor Pharmaceutical Limited reported quarterly long term debt of 214.3 Thousand CNY for 2023 Q2, up 20.66% from previous quarter.
  • Kintor Pharmaceutical Limited reported quarterly long term debt of 135.69 Million CNY for 2023 Q4, up 63217.78% from previous quarter.

Annual Long Term Debt Chart of Kintor Pharmaceutical Limited (2023 - 2014)

Historical Annual Long Term Debt of Kintor Pharmaceutical Limited (2023 - 2014)

Year Long Term Debt Long Term Debt Growth
2023 135.69 Million CNY 76302.03%
2022 177.6 Thousand CNY 20.41%
2021 147.5 Thousand CNY 9.34%
2020 134.9 Thousand CNY -94.16%
2019 2.31 Million CNY 10404.55%
2018 22 Thousand CNY -99.93%
2017 30 Million CNY 0.0%
2016 - CNY 0.0%
2015 - CNY 0.0%
2014 - CNY 0.0%

Peer Long Term Debt Comparison of Kintor Pharmaceutical Limited

Name Long Term Debt Long Term Debt Difference
Uni-Bio Science Group Limited 30.61 Million HKD -343.258%
CK Life Sciences Int'l., (Holdings) Inc. 4.27 Billion HKD 96.824%